Clinical trial
An Exploratory, Pilot Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine
NCT05374317 is registered in ClinicalTrials.gov with US Army Medical Research Institute of Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory, Pilot Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine
- Lead sponsor
- US Army Medical Research Institute of Infectious Diseases
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 7, 2021
- Completion date
- November 2, 2022
- Enrollment
- 88 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
yellow fever vaccination reaction